---
title: Plausibility-Driven Prioritization of Candidate Biomedical Annotations
url: http://arxiv.org/abs/2607.20163v1
type: paper-summary
date: 2026-07-23
source_paper: 2026-07-22_13-58-57Z_Plausibility_DrivenPrioritizationofCandidateBiomed.md
generated_at: 2026-07-23 23:22
model: nvidia/nemotron-3-nano-4b
---

## Summary
The paper introduces a framework that uses biomedical knowledge graphs to estimate the plausibility of automatically generated biological annotations. By training relation‑specific classifiers with community‑based negative sampling, it creates reliability scores and combines them into comprehensive plausibility measures that outperform simple confidence estimates. Experiments on five large bioKGs show an average 5.8% increase in balanced accuracy and more effective prioritization for expert review.

## Key Takeaways
- The proposed method trains binary classifiers per relation using community‑based negative sampling, which boosts classifier robustness and balanced accuracy by about 5.8%.  
- Plausibility measures integrate classifier confidence, reliability estimates, and alternative relationships between entities to capture multiple biologically meaningful links.  
- These integrated scores enable a more precise ranking of candidate annotations for manual curation compared with using confidence alone.

## Context
Automated annotation generation in biomedical literature generates vast numbers of candidates that must be validated by experts, creating a bottleneck in knowledge curation. Traditional approaches rely solely on model confidence, which can be misleading without ground truth. Leveraging structured biological knowledge graphs offers a principled way to improve validation accuracy while maintaining human oversight.

## Implications
The results demonstrate that integrating bioKGs into AI‑driven annotation pipelines can significantly reduce the volume of expert workload and enhance curation efficiency. Practitioners in biomedical data management can adopt this approach to prioritize high‑plausibility candidates, accelerating the integration of validated knowledge into downstream applications such as drug discovery and disease modeling.

## Original Paper Reference
- **Source**: [Original Paper](http://arxiv.org/abs/2607.20163v1)
